UAB Comprehensive Cancer Center

Site:	UAB Comprehensive Cancer Center	Go to their website
Address:	1802 6th Ave. South
City:	Birmingham
State:	AL
Zip:	35294
Country:	USA

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active	Bezuclastinib plus Sunitinib	NCT05208047
2	A Phase II Study of IMC-A12 in Children With Relapsed/Refractory Solid Tumors	Does not allow GIST	Active	IMC-A12	NCT00831844
1/2	Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors	Terminated	Closed	CB-839 + Talazoparib	NCT03875313
3	Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID)	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01271712
2	Evaluation of Patients With Bulky GIST Using Sunitinib	Terminated	Closed	Sunitinib	NCT01054911
2	Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study	Active, not recruiting	Closed	CB-839	NCT03872427